Oxford BioTherapeutics

Matthew Metzger, our Business Development Manager, will be presenting at the 4th Annual ADC Target Selection Summit in San Diego, CA, which will take place December 10-12, 2024   Matt’s presentation will be in the stream: "Constructing a Methodology of Target Selection to Ensure Efficiency of Strategy Whilst Prioritizing Innovation".   Join Matt and fellow professionals in Target Selection, Biology, Translational Science and Bioinformatics, as they discuss the challenge of building an advanced target selection strategy, enhancing the frequency of novel targets in the ADC space.   #ADCTargetSelectionSummit #OxfordBioTherapeutics #TargetSelection #ADC #MassSpectrometry #Innovation

We're thrilled to announce that Dr Lindsey Hudson, Senior Director of Business Development, will be presenting at the 6th Annual Targeted Radiopharmaceutical Summit Europe in Amsterdam! Join Lindsey Hudson at the Scientific Poster Session to explore cutting-edge developments in targeted radiopharmaceuticals. Lindsey will be showcasing our innovative research and demonstrating Oxford BioTherapeutics’ commitment to advancing targeted therapies. Looking forward to seeing you there! #TargetedRadiopharmaceuticals #OxfordBioTherapeutics #OncologyInnovation #TRPSummitEurope

We are excited to announce that Oxford BioTherapeutics will be well-represented at WADC 2024 in San Diego.   Our CEO, Christian Rohlff will be presenting our lead proprietary clinical asset, OBT076, a first-in-class ADC targeting the CD205 receptor on tumor and immune-suppressive cells.   Additionally, Associate Director, Yu-Tzu Tai will share insights on our OGAP®-Verify proteomic target discovery platform, which is designed to identify novel membrane-bound targets.    Business Development Manager, Matthew Metzger will also be on hand for partnering discussions, exploring new collaborations in target discovery and ADC development.    We would love to connect with you to explore how OGAP®-Verify can help strengthen your pipeline and drive new breakthroughs. Feel free to contact us to arrange a meeting!   #WADC2024 #TargetDiscovery #ADC #Biotech #Collaboration

We are excited to announce that Abbie Houghton, Business Development Associate, and Lindsey Hudson, Senior Director of Business Development and Alliance Management, will be attending BIO-Europe next month in Stockholm, Sweden!   As BIO-Europe celebrates 30 years of fostering partnerships, we’re looking forward to connecting with innovators across the biotech landscape and exploring new collaboration opportunities.   Earlier this year, we launched our OGAP®-Verify Target Discovery Platform, offering advancements in sensitivity and specificity for novel cancer targets. We’re eager to discuss how this platform can drive joint projects and accelerate therapeutic innovation.   If you’re attending BIO-Europe and would like to meet our team to explore collaboration opportunities, feel free to reach out.   #BIOEurope2024 #BiotechPartnerships #Innovation #TargetDiscovery

October is Breast Cancer Awareness Month.   1 in 8 women will be diagnosed with breast cancer in their lifetime. This month is a reminder to raise awareness, support research, and promote early detection, which can save lives. At OBT we are dedicated to transforming the landscape of cancer research by identifying novel cancer targets that can unlock new avenues for treatment. Let’s continue to advocate for those affected by breast cancer.   #BreastCancerAwareness #CancerResearch #EarlyDetection

Last week, our CEO Christian Rohlff spoke with Amy Brown from @BiotechTV! In this interview, Christian details the expertise OBT has built and describes our promising pipeline assets, including partnerships with Boehringer Ingelheim and more.   Our proprietary OGAP®-Verify platform, designed to discover novel membrane-based protein targets for antibody-based therapeutics, continues to drive groundbreaking innovations. This technology enables us to identify first-in-class cancer targets for both our internal pipeline and collaborative efforts.   🎥 Watch the full video here: https://lnkd.in/gY9cRgGE   Thank you BiotechTV for the great discussion!   #Biotech #CancerResearch #Innovation #OGAP #ImmunoOncology #TargetDiscovery

September is Blood Cancer Awareness Month   Every September, we come together as a global community to shine a light on blood cancer—one of the most prevalent yet under-recognized cancers. This month, we turn everything red to raise awareness about the signs, symptoms, and the urgent need for early diagnosis.   At OBT we are committed to making a difference through our innovative work in discovering and developing antibody-drug conjugates to target both solid and liquid tumors. Our mission is to address the unmet needs in oncology by advancing the treatment landscape, exploring new therapeutic targets and ultimately improving patient outcomes.   Let’s use this month to support the blood cancer community.   #BloodCancerAwareness #BloodCancerMonth #RedSeptember #RaiseAwareness

We are happy to announce that Andrew Dickinson, our VP of Clinical Operations, and Harald Haeske, our Chief Medical Officer, will be attending the ESMO Congress 2024 in Barcelona, Spain, from September 13-17.   Andrew and Harald are looking forward to engaging with existing and potential partners, sharing insights, and exploring innovative solutions that can drive the future of oncology.   If you’re attending, don't miss the chance to connect with them and discuss how we can collaborate to make a difference in patient care.   #ESMO2024 #Oncology #ClinicalOperations #MedicalInnovation

We're Hiring! 📌   Oxford BioTherapeutics is a pioneering clinical-stage oncology company, specializing in the development of antibody-based therapeutics. As a Senior Lab Operations Technician, you will play a key role in supporting our cutting-edge research activities. This position is based in our San Jose, California site.   In this role, you will oversee various operational aspects of our biological lab, including maintaining equipment, managing lab supplies, training staff, and ensuring a safe and productive laboratory environment. You’ll be working with one of the world’s largest cancer-specific membrane protein libraries through our OGAP® platform, contributing to the development of first-in-class therapies.   Interested in joining our team? Click the link below to apply. https://lnkd.in/eSF3ZyCP   #hiring #biotech #oncology #SanJose